Journal of Cancer Research and Pharmacology

Journal of Cancer Research and Pharmacology

Curcumin-Mediated Modulation of miR-21-5p and miR-126-3p Enhances PTEN Expression and Suppresses VEGF in Caski Cell line

Document Type : Original Article

Author
Department of Plant Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
Abstract
Background and Aims: Curcumin, a natural polyphenolic compound from Curcuma longa, exhibits anti-cancer properties by modulating miRNAs and targeting pathways like PI3K/Akt and angiogenesis. This study investigates the effects of curcumin on the expression of miR-21-5p, miR-210-3p, miR-126-3p, and miR-214-3p in HPV-16-positive CaSki cervical cancer cells, and their correlations with PTEN and VEGF.
Methods: CaSki cells were cultured and treated with curcumin at a sub-IC50 concentration (80 μM) for 48 hours, determined via MTT assay (IC50 = 96 μM). Total RNA was extracted using TRIzol, and qRT-PCR was used to assess PTEN, VEGF (normalized to GAPDH), and miRNA expression (normalized to U6). Data from nine biological replicates per group were analyzed using Welch’s t-test for comparisons and Pearson’s correlation for relationships.
Results: Curcumin significantly upregulated PTEN (1.861 ± SD, p=0.004; ~3.6-fold) and downregulated VEGF (-2.137 ± SD, p=0.006; ~0.23-fold). miRNA modulation included a trend toward miR-21-5p downregulation (-1.024 ± SD, p=0.057; ~0.48-fold), no change in miR-210-3p (p=0.344), and upregulation of miR-126-3p (1.674 ± SD, p=0.003; ~3.2-fold) and miR-214-3p (1.669 ± SD, p=0.019; ~3.2-fold). Correlations revealed miR-21-5p negatively associated with PTEN (r=-0.51, p=0.03) and positively with VEGF (r=0.57, p=0.01); miR-126-3p positively with PTEN (r=0.41, p=0.09) and negatively with VEGF (r=-0.49, p=0.03); miR-214-3p negatively with PTEN (r=-0.36, p=0.14).
Conclusions: Curcumin epigenetically modulates miRNAs in CaSki cells, enhancing PTEN and suppressing VEGF through regulatory networks involving miR-21-5p and miR-126-3p. These findings elucidate curcumin's anti-cancer mechanisms and support its potential as an adjunctive therapy for cervical cancer, warranting further in vivo validation.
Keywords

1.         Li Z, Liu P, Yin A, et al. Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer. Int J Cancer. 2025; 157 (2): 288-97. doi:10.7150/jca.101420 PMid:40026066
2.         Wu J, Jin Q, Zhang Y, et al. Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022. J Natl Cancer Cent. 2025;5(3):322-9. doi:10.1016/j.jncc.2024.11.006 PMid:40693230 PMCid:PMC12276544
3.         Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10. doi:10.3322/caac.21871 PMid:39817679 PMCid:PMC11745215
4.         Sadri Nahand J, Moghoofei M, Salmaninejad A, et al. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: a review. Int J Cancer. 2020;146(2):305-20. doi:10.1002/ijc.32688 PMid:31566705 PMCid:PMC6999596
5.         Hussen BM, Ahmadi G, Marzban H, et al. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. Microb Pathog. 2021;150:104692. doi:10.1016/j.micpath.2020.104692 PMid:33301856                
6.         Nahand JS, Khanaliha K, Mirzaei H, et al. Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer. BMC Cancer. 2021;21(1):926. doi:10.1186/s12885-021-08658-y PMid:34399719 PMCid:PMC8369687                   
7.         Shiri Aghbash P, Rasizadeh R, Sadri Nahand J, et al. The role of immune cells and inflammasomes in Modulating cytokine responses in HPV-Related cervical cancer. Int Immunopharmacol. 2025;145:113625. doi:10.1016/j.intimp.2024.113625 PMid:39637578       
8.         Rasizadeh R, Shiri Aghbash P, Mokhtarzadeh A, et al. Novel strategies in HPV‑16‑related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy. Gene. 2025;932:148904. doi:10.1016/j.gene.2024.148904 PMid:39218415     
9.         Taghizadieh M, Kalantari M, Bakhshali R, et al. To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death. Cancer Cell Int. 2025;25(1):153. doi:10.1186/s12935-025-03786-y PMid:40251577 PMCid:PMC12008905               
10.       Nahand JS, Rabiei N, Fathazam R, et al. Oncogenic viruses and chemoresistance: What do we know? Pharmacol Res. 2021;170:105730. doi:10.1016/j.phrs.2021.105730 PMid:34119621
11.       Bayat M, Golestani S, Motlaghzadeh S, et al. War or peace: Viruses and metastasis. Biochim Biophys Acta Rev Cancer. 2024;1879(6): 189179. doi:10.1016/j.bbcan.2024.189179 PMid:39299491        
12.       Zaman MS, Chauhan N, Yallapu MM, et al. Curcumin Nanoformulation for Cervical Cancer Treatment. Sci Rep. 2016; 6(1): 20051. doi:10.1038/srep20051 PMid:26837852 PMCid:PMC4738284
13.       Ming T, Tao Q, Tang S, et al. Curcumin: An epigenetic regulator and its application in cancer. Biomed Pharmacother. 2022;156: 113956. doi:10.1016/j.biopha.2022.113956 PMid:36411666       
14.       Zhou S, Zhang S, Shen H, et al. Curcumin inhibits cancer progression through regulating expression of microRNAs. Tumour Biol. 2017;39(2): 1010428317691680. doi:10.1177/1010428317691680 PMid:28222667
15.       Asiri A, Bokahri BT, Sadaf, et al. Curcumin, EGCG and apigenin in cervical cancer: mechanistic insights and therapeutic potential. Front Pharmacol. 2025;16. doi:10.3389/fphar.2025.1592395 PMid:40667502 PMCid:PMC12259677                
16.       Mirzaei H, Rahimian N, Mirzaei HR, et al. MicroRNA biogenesis and function. In: Mirzaei H, Rahimian N, Hamblin MR, eds. Exosomes and MicroRNAs in Biomedical Science. Springer; 2022:1-9. doi:10.1007/978-3-031-79177-2_1       
17.       Rahimian N, Nahand JS, Hamblin MR, et al. Exosomal MicroRNA Profiling. In: Rani S, ed. MicroRNA Profiling: Methods and Protocols. Springer US; 2023:13-47. doi:10.1007/978-1-0716-2823-2_2 PMid:36441452                  
18.       Bayat M, Sadri Nahand J. Exosomal miRNAs: the tumor's trojan horse in selective metastasis. Mol Cancer. 2024;23(1):167. doi:10.1186/s12943-024-02081-0 PMid:39164756 PMCid:PMC11334467  
19.       Chen J, Xu T, Chen C. The critical roles of miR-21 in anti-cancer effects of curcumin. Ann Transl Med. 2015;3(21):330.
20.       Xu J, Zhang W, Lv Q, et al. Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN. Oncol Rep. 2015;33(6):3108-16. doi:10.3892/or.2015.3931 PMid:25963606    
21.       Ghafouri-Fard S, Abak A, Shoorei H, et al. Regulatory role of microRNAs on PTEN signaling. Biomed Pharmacother. 2021; 133: 110986. doi:10.1016/j.biopha.2020.110986 PMid:33166764
22.       Lu WJ, Liang HB, Li YF, et al. MicroRNA-210-3p Targets RGMA to Enhance the Angiogenic Functions of Endothelial Progenitor Cells Under Hypoxic Conditions. Front Cell Neurosci. 2019;13:223. doi:10.3389/fncel.2019.00223 PMid:31164807 PMCid:PMC6536652
23.       Cao G, Fan P, Ma R, et al. MiR-210 regulates lung adenocarcinoma by targeting HIF-1α. Heliyon. 2023;9(5):e16079. doi:10.1016/j.heliyon.2023.e16079 PMid:37215862 PMCid:PMC10192744
24.       Zhao N, Na K, Sun W, et al. Plasma microRNA-210 is associated with VEGF-A and EphrinA3 and relates to coronary collateral circulation in patients with coronary heart disease: a cross-sectional study. BMC Cardiovasc Disord. 2025;25(1):547. doi:10.1186/s12872-025-05013-y PMid:40717103 PMCid:PMC12302828  
25.       Du C, Lv Z, Cao L, et al. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. J Transl Med. 2014;12:259. doi:10.1186/s12967-014-0259-1 PMid:25240815 PMCid:PMC4189615                
26.       Guo B, Gu J, Zhuang T, et al. MicroRNA-126: From biology to therapeutics. Biomed Pharmacother. 2025;185:117953. doi:10.1016/j.biopha.2025.117953 PMid:40036996 
27.       Caporali S, Amaro A, Levati L, et al. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A. J Exp Clin Cancer Res. 2019;38 (1):272. doi:10.1186/s13046-019-1238-4 PMid:31227006 PMCid:PMC6588909          
28.       Akaray I, Ozal SA, Sancar H, et al. miR-124, miR-126-3p, and miR-200b: Potential therapeutic targets for VEGF-mediated complications in proliferative diabetic retinopathy. Indian J Ophthalmol. 2025;73(6):886-92. doi:10.4103/IJO.IJO_1791_24 PMid:39728608 PMCid:PMC12178365
29.       Chen Z, Deng X, Lu Y, et al. Role of miRNA‑214‑3p in cancer (Review). Oncol Rep. 2025;54(4):123. doi:10.3892/or.2025.8957 PMid:40747717 PMCid:PMC12340666
30.       Wang X, Xu J, Hua F, et al. MiR-214-3p suppresses cervical cancer cell metastasis by downregulating THBS2. Cell Mol Biol (Noisy-le-grand). 2023;69(9):195-200. doi:10.14715/cmb/2023.69.9.30 PMid:37807313
31.       Sukmana BI, Al-Hawary SIS, Abosaooda M, et al. A thorough and current study of miR-214-related targets in cancer. Pathol Res Pract. 2023;249:154770. doi:10.1016/j.prp.2023.154770 PMid:37660658
32.       Eslami M, Khazeni S, Khanaghah XM, et al. MiRNA-related metastasis in oral cancer: moving and shaking. Cancer Cell Int. 2023;23(1):182. doi:10.1186/s12935-023-03022-5 PMid:37635248 PMCid:PMC10463971              
33.       Pourhanifeh MH, Darvish M, Tabatabaeian J, et al. Therapeutic role of curcumin and its novel formulations in gynecological cancers. J Ovarian Res. 2020;13(1):130. doi:10.1186/s13048-020-00731-7 Mid:33148295 PMCid:PMC7643381                   
34.       Bhattacharjee R, Das SS, Biswal SS, et al. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol. 2022; 174: 103675. doi:10.1016/j.critrevonc.2022.103675 PMid:35381343
35.       Liu Y, Sun H, Makabel B, et al. The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review). Oncol Rep. 2019;42(1):20-34. doi:10.3892/or.2019.7148 PMid:31059075 PMCid:PMC6549103                 
36.       Zoi V, Kyritsis AP, Galani V, et al. The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway. Cancers (Basel). 2024;16(8). doi:10.3390/cancers16081554 PMid:38672636 PMCid:PMC11048628
37.       Rahmani AH, Al Zohairy MA, Aly SM, et al. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int. 2014;2014:761608. doi:10.1155/2014/761608 PMid:25295272 PMCid:PMC4176907
38.       Ameer SF, Mohamed MY, Elzubair QA, et al. Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment? Front Oncol. 2024;14. doi:10.3389/fonc.2024.1438040 PMid:39507759 PMCid:PMC11537944
39.       Chen Y, Su C, Cai Y, et al. miR-21 promotes cervical cancer by regulating NTF3. Sci Rep. 2025;15(1):2442. doi:10.1038/s41598-025-85888-1 PMid:39828780 PMCid:PMC11743774     
40.       Aguilar-Martínez SY, Campos-Viguri GE, Medina-García SE, et al. MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway. Int J Mol Sci. 2024;25(7). doi:10.3390/ijms25074086 PMid:38612895 PMCid:PMC11012906
41.       Mitra T, Prusty M, Elangovan S. Identification and validation of miR-21 key genes in cervical cancer through an integrated bioinformatics approach. Comput Biol Chem. 2024;113:108280.
doi:10.1016/j.compbiolchem.2024.108280 PMid:39571453 
42.       Tang Y, Zhao Y, Ran J, et al. MicroRNA‑21 promotes cell metastasis in cervical cancer through modulating epithelial‑mesenchymal transition. Oncol Lett. 2020;19 (4): 3289-95. doi:10.3892/ol.2020.11438 PMid:32256824 PMCid:PMC7074379
43.       Chauhan P, Pramodh S, Hussain A, et al. Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses. Front Cell Dev Biol. 2024;12:1397945. doi:10.3389/fcell.2024.1397945 PMid:39263322 PMCid:PMC11387185
44.       Endale HT, Mariye YF, Negash HK, et al. MiRNA in cervical cancer: Diagnosis to therapy: Systematic review. Heliyon. 2024;10(3): e24398. doi:10.1016/j.heliyon.2024.e24398 PMid:38317930 PMCid:PMC10839805      
45.       He Y, Lin J, Ding Y, et al. A systematic study on dysregulated micro RNA s in cervical cancer development. Int J Cancer. 2016;138(6):1312-27. doi:10.1002/ijc.29618 PMid:26032913 
46.       Wang H, Wang L, Zhou X, et al. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway. Biomed Res Int. 2020;2020: 2125656. doi:10.1155/2020/2125656 PMid:32695810 PMCid:PMC7368228
47.       Yang Y, Zhang J, Xia T, et al. MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. Oncol Rep. 2016;36(5):2553-62. doi:10.3892/or.2016.5129 PMid:27666683
48.       Pasculli B, Barbano R, Rendina M, et al. Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel. Sci Rep. 2019;9(1):14913. doi:10.1038/s41598-019-51581-3 PMid:31624308 PMCid:PMC6797767          
49.       Lu G, Wu X, Zhao Z, et al. MicroRNA-126 regulates the phosphatidylinositol-3 kinase (PI3K)/protein kinase B (AKT) pathway in SLK cells in vitro and the expression of its pathway members in Kaposi's sarcoma tissue. Medicine (Baltimore). 2018; 97(35):e11855. doi:10.1097/MD.0000000000011855 PMid:30170375 PMCid:PMC6392886                  
50.       Di Paolo D, Pontis F, Moro M, et al. Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling. Mol Oncol. 2021;15(11):2969-88. doi:10.1002/1878-0261.13036 PMid:34107168 PMCid:PMC8564655  
51.       Ichikawa R, Kawasaki R, Iwata A, et al. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway. Oncol Rep. 2020; 43(4):1300-8. doi:10.3892/or.2020.7512 PMid:32323808 PMCid:PMC7057934
52.       Song L, Li D, Gu Y, et al. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway. Clin Lung Cancer. 2016;17(5):e65-e75. doi:10.1016/j.cllc.2016.03.012 PMid:27236384
53.       Jalil AT, Abdulhadi MA, Al-Ameer LR, et al. The emerging role of microRNA-126 as a potential therapeutic target in cancer: a comprehensive review. Pathol Res Pract. 2023;248:154631. doi:10.1016/j.prp.2023.154631 PMid:37393667     
54.       Yang Y, Liu Y, Li G, et al. microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2. Oncol Lett. 2018; 16(5): 5679-86. doi:10.3892/ol.2018.9363 PMid:30344723 PMCid:PMC6176260
55.       Penna E, Orso F, Taverna D. miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions. J Invest Dermatol. 2015;135(4):960-9. doi:10.1038/jid.2014.479 PMid:25501033     
56.       Fang YY, Tan MR, Zhou J, et al. miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1. Onco Targets Ther. 2019;12:9449-58. doi:10.2147/OTT.S181037 PMCid:PMC6875683
57.       Schwarzenbach H, Milde-Langosch K, Steinbach B, et al. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat. 2012;134(3): 933-41. doi:10.1007/s10549-012-1988-6 PMid:22350790
58.       Yang TS, Yang XH, Wang XD, et al. MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int. 2013;13(1):68. doi:10.1186/1475-2867-13-68 PMid:23834902 PMCid:PMC3716801                
59.       Liu J, Chen W, Zhang H, et al. miR-214 targets the PTEN-mediated PI3K/Akt signaling pathway and regulates cell proliferation and apoptosis in ovarian cancer. Oncol Lett. 2017; 14(5):5711-8. doi:10.3892/ol.2017.6953 PMid:29113199 PMCid:PMC5661372
60.       Ma J, Sun X, Wang Y, et al. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling. Cell Commun Signal. 2019;17(1): 119. doi:10.1186/s12964-019-0432-5 PMid:31500630 PMCid:PMC6734448  
61.       Medford AR, Douglas SK, Godinho SI, et al. Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury. Respir Res. 2009;10(1):27. doi:10.1186/1465-9921-10-27 PMid:19358726 PMCid:PMC2674417  
62.       Kwon N, Lee KE, Singh M, et al. Suitable primers for GAPDH reference gene amplification in quantitative RT-PCR analysis of human gene expression. Gene Rep. 2021;24:101272. doi:10.1016/j.genrep.2021.101272                   
63.       Zhang WY, Wang HB, Deng CY. Effects of miR-214-5p and miR-21-5p in hypoxic endometrial epithelial-cell-derived exosomes on human umbilical cord mesenchymal stem cells. World J Stem Cells. 2024; 16 (11):906-25. doi:10.4252/wjsc.v16.i11.906 PMid:39619875 PMCid:PMC11606348
64.       Hayder H, Fu G, Nadeem L, et al. Overexpression of miR-210-3p Impairs Extravillous Trophoblast Functions Associated with Uterine Spiral Artery Remodeling. Int J Mol Sci. 2021;22(8). doi:10.3390/ijms22083961 PMid:33921262 PMCid:PMC8069107
65.       Kang K, Zhang X, Liu H, et al. A novel real-time PCR assay of microRNAs using S-Poly (T), a specific oligo (dT) reverse transcription primer with excellent sensitivity and specificity. PLoS One. 2012; 7 (11): e48536. doi:10.1371/journal.pone.0048536 PMid:23152780 PMCid:PMC3496722  
66.       Niu Y, Zhang L, Qiu H, et al. An improved method for detecting circulating microRNAs with S-Poly(T) Plus real-time PCR. Sci Rep. 2015;5 (1):15100. doi:10.1038/srep15100 PMid:26459910 PMCid:PMC4602224  
67.       Cai H, Miao M, Wang Z. miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1. Oncol Lett. 2018;16(2):2620-8. doi:10.3892/ol.2018.8927 PMid:30013657 PMCid:PMC6036594
68.     Mabin JW, Lewis PW, Brow DA, et al. Human spliceosomal snRNA sequence variants generate variant spliceosomes. RNA. 2021; 27 (10): 1186-203. doi:10.1261/rna.078768.121 PMid:34234030 PMCid:PMC8457000
Volume 1, Issue 2
Autumn 2025
Pages 89-100

  • Receive Date 14 September 2025
  • Revise Date 13 November 2025
  • Accept Date 16 November 2025